
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
Oncology Today with Dr Neil Love
00:00
Pivotal phase 3 studies underway
Paul outlines Successor 1 and 2 comparisons aiming for FDA approval and mentions the Excalibur study.
Play episode from 10:11
Transcript


